Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdelhalim Bentoucha"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 46:3193-3196
To identify the most active curative treatment of Buruli ulcer, two regimens incorporating the use of rifampin (RIF) were compared with the use of RIF alone in a mouse footpad model of Mycobacterium ulcerans infection. Treatments began after footpad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f8a2fc0f0369bd3e8b9c6e64805d00
https://doi.org/10.1128/aac.46.10.3193-3196.2002
https://doi.org/10.1128/aac.46.10.3193-3196.2002
Autor:
Herve Dega, Jérôme Robert, Vincent Jarlier, Jacques H. Grosset, Nacer Lounis, Abdelhalim Bentoucha
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:3109-3112
Mice infected in the left hind footpad with 5 log 10 acid-fast bacilli of Mycobacterium ulcerans were divided into an untreated control group and 17 treatment groups that received one of the following regimens for 4 weeks (all doses in milligrams per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f4950fcaead10110521a21050aac10
https://doi.org/10.1128/aac.45.11.3109-3112.2001
https://doi.org/10.1128/aac.45.11.3109-3112.2001
Publikováno v:
Antimicrobial Agents and Chemotherapy. 44:2919-2921
Bactericidal activities of HMR 3647 (HMR), moxifloxacin (MXFX), and rifapentine (RPT) against Mycobacterium leprae , measured by the proportional bactericidal technique in the mouse footpad system, were compared with those of the established antilepr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a59e70602647b1aa4ac00db49be287d
https://doi.org/10.1128/aac.44.10.2919-2921.2000
https://doi.org/10.1128/aac.44.10.2919-2921.2000
Autor:
Abdelhalim Bentoucha, Baohong Ji, Nacer Lounis, Chantal Truffot-Pernot, J. Grosset, Giorgio Roscigno, Richard J. O'Brien, Andrew N. Vernon
Publikováno v:
Antimicrobial agents and chemotherapy. 45(12)
Mice infected with 1.6 × 10 7 CFU of Mycobacterium tuberculosis were treated 14 days later for 6 months with a regimen of once-weekly 10 mg of rifapentine and 75 mg of isoniazid per kg of body weight supplemented with either 150 mg of streptomycin p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced81a00d59caa3711f05e74276bf48a
https://pubmed.ncbi.nlm.nih.gov/11709328
https://pubmed.ncbi.nlm.nih.gov/11709328
Autor:
Chantal Truffot-Pernot, Abdelhalim Bentoucha, Baohong Ji, Jérôme Robert, Jacques H. Grosset, Nacer Lounis
Publikováno v:
Antimicrobial agents and chemotherapy. 45(11)
Mice were infected intravenously with 3.5 × 10 7 CFU of Mycobacterium xenopi and treated with various clarithromycin-containing regimens or left untreated for 4 weeks. All nine of the clarithromycin-containing regimens reduced the CFU counts to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8305b2f9cbcc925c248fc3d68933f2
https://pubmed.ncbi.nlm.nih.gov/11600387
https://pubmed.ncbi.nlm.nih.gov/11600387